The distribution of constitutional and somatic mutations in the neurofibromatosis 2 gene

被引:43
作者
Baser, ME [1 ]
机构
[1] St Marys Hosp, Dept Med Genet, Acad Unit Med Genet, Manchester M13 0JH, Lancs, England
关键词
neurofibromatosis; 2; NF2; database; CpG dinucleotide; merlin;
D O I
10.1002/humu.20317
中图分类号
Q3 [遗传学];
学科分类号
071007 [遗传学]; 090102 [作物遗传育种];
摘要
Constitutional heterozygous inactivating mutations in the neurofibromatosis 2 (NF2) tumor suppressor gene cause the autosomal dominant disease NF2, and biallelic inactivating somatic NF2 mutations are found in a high proportion of unilateral sporadic vestibular schwannoma (USVS) and sporadic meningioma. We surveyed the distributions of constitutional NF2 mutations in 823 NF2 families, 278 somatic NF2 mutations in USVS, and 208 somatic NF2 mutations in sporadic meningioma. Based on the available NTF2 mutation data, the most dominant influence on the spectra of mutations in exons 1-15 are C > T transitions that change arginine codons (CGA) to stop codons (TGA) due to spontaneous deamination of methylcytosine to thymine in CpG dinucleotides. The paucity of reported mutations in exon 9 and the absence of reported mutations in exons 16 and 17 may be related to structure-function relationships in the NF2 protein.
引用
收藏
页码:297 / 306
页数:10
相关论文
共 70 条
[1]
Microdeletions and microinsertions causing human genetic disease: Common mechanisms of mutagenesis and the role of local DNA sequence complexity [J].
Ball, EV ;
Stenson, PD ;
Abeysinghe, SS ;
Krawczak, M ;
Cooper, DN ;
Chuzhanova, NA .
HUMAN MUTATION, 2005, 26 (03) :205-213
[2]
Baser M. E., 2002, Neurology, V59, P1759
[3]
Age associated increase in the prevalence of chromosome 22q loss of heterozygosity in histological subsets of benign meningioma [J].
Baser, ME ;
Poussaint, TY .
JOURNAL OF MEDICAL GENETICS, 2006, 43 (03) :285-287
[4]
The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2 [J].
Baser, ME ;
Kuramoto, L ;
Woods, R ;
Joe, H ;
Friedman, JM ;
Wallace, AJ ;
Ramsden, RT ;
Olschwang, S ;
Bijlsma, E ;
Kalamarides, M ;
Papi, L ;
Kato, R ;
Carroll, J ;
Lázaro, C ;
Joncourt, F ;
Parry, DM ;
Rouleau, GA ;
Evans, DGR .
JOURNAL OF MEDICAL GENETICS, 2005, 42 (07) :540-546
[5]
Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: A population-based study [J].
Baser, ME ;
Kuramoto, L ;
Joe, H ;
Friedman, JM ;
Wallace, AJ ;
Gillespie, JE ;
Ramsden, RT ;
Evans, DGR .
AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 75 (02) :231-239
[6]
Genotype-phenotype correlations for cataracts in neurofibromatosis 2 [J].
Baser, ME ;
Kuramoto, L ;
Joe, H ;
Friedman, JM ;
Wallace, AJ ;
Ramsden, RT ;
Evans, DGR .
JOURNAL OF MEDICAL GENETICS, 2003, 40 (10) :758-760
[7]
Predictors of the risk of mortality in neurofibromatosis 2 [J].
Baser, ME ;
Friedman, JM ;
Aeschliman, D ;
Joe, H ;
Wallace, AJ ;
Ramsden, RT ;
Evans, DGR .
AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) :715-723
[8]
HIGH-FREQUENCY OF INACTIVATING MUTATIONS IN THE NEUROFIBROMATOSIS TYPE-2 GENE (NF2) IN PRIMARY MALIGNANT MESOTHELIOMAS [J].
BIANCHI, AB ;
MITSUNAGA, SI ;
CHENG, JQ ;
KLEIN, WM ;
JHANWAR, SC ;
SEIZINGER, B ;
KLEY, N ;
KLEINSZANTO, AJP ;
TESTA, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (24) :10854-10858
[9]
MUTATIONS IN TRANSCRIPT ISOFORMS OF THE NEUROFIBROMATOSIS-2 GENE IN MULTIPLE HUMAN TUMOR TYPES [J].
BIANCHI, AB ;
HARA, T ;
RAMESH, V ;
GAO, JZ ;
KLEINSZANTO, AJP ;
MORIN, F ;
MENON, AG ;
TROFATTER, JA ;
GUSELLA, JF ;
SEIZINGER, BR ;
KLEY, N .
NATURE GENETICS, 1994, 6 (02) :185-192
[10]
ERM proteins and merlin: Integrators at the cell cortex [J].
Bretscher, A ;
Edwards, K ;
Fehon, RG .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (08) :586-599